TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Socialisation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: CPT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum sRANKL concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Serum OPG concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Markers of myocardial ischaemia (TnT and GPBB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Expression differences in lncRNAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluoride concentration in biofilm fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: primary composite outcome
Endpoint domain: Adverse events/effects
Primary endpoint: Incremental cost-effectiveness ratio (ICER) per quality-adjusted life year (QALY) gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mortality or all-cause hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: mortality alone
Endpoint domain: Mortality/survival
Primary endpoint: mortality or cardiovascular hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Total psoriasis score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction of skin involvement with psoriasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: PSA fall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum forced expiratory flow rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: First attempt needle puncture success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Guidewire passed in first attempt success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to clinical stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful pupil dilation to 7 mm within 40 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of patients with low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in mechanical allodynia intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in cold allodynia intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral Blood Flow (CBF) in the frontal cortex ipsilateral to the aneurysm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Successful treatment of H. pylori infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total number of LDL particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Very-low-density lipoprotein particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean percentage time in the target zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: averaged standardized difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic sensitivity for pheochromocytoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Invasive breast cancer incidence
Endpoint domain: Mortality/survival
Primary endpoint: Oropharyngeal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acute urticaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: visual acuities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fixation point scotomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WOMAC functional difficulty score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PDCD4 mRNA and protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum IL‐10 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean VAS values
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Mean CPS values
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Youth's sun safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gastric colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast cancer-free interval (BCFi)
Endpoint domain: Mortality/survival
Primary endpoint: Distant recurrence-free interval (D-RFi)
Endpoint domain: Mortality/survival
Primary endpoint: Survival after distant recurrence
Endpoint domain: Mortality/survival
Primary endpoint: improvements in neuropsychological examination protocol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Use of PRN analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barriers to managing cancer pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in urinary tract symptoms (IPSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Qmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microalbuminuria normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Basement membrane thickness changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetic glomerulopathy index changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early adverse contrast medium-related reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Effects on electrophysiologic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of severe hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caregiver appreciation of the HPV vaccination program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Global Pain Intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessments in Ankylosing Spondylitis 20 responder criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: joint attention with peers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eye gaze towards persons
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SRS scores
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Desire to eat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: symptomatic intracerebral hemorrhage rate
Endpoint domain: Adverse events/effects
Primary endpoint: NIHSS score at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HbA1c target achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confirmed hypoglycaemic events
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement after therapy on the scale from 0 (dead) to 1.0 (full health)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Surface area of enamel powder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pore volume of enamel powder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eligibility for DSD
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: clinician time requirements
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: AUC and C(max) of lobeglitazone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intentions to register as organ donors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MATRICS Consensus Cognitive Battery composite score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle fatigue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response defined as >50% reduction in HRSD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression of 1-2
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of asymptomatic hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of preterm delivery
Endpoint domain: Mortality/survival
Primary endpoint: Drowsiness
Endpoint domain: Adverse events/effects
Primary endpoint: Irritability
Endpoint domain: Adverse events/effects
Primary endpoint: Pain and swallowing dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in urinary protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: first phase decline in HCV RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RVR (Rapid Virologic Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: final therapeutic outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: orbital uptake of (99m)Tc‐P829
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-meter walking velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: summary performance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oropharyngeal swallowing efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean serum area of the curve of glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean serum area of the curve of insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: C/I values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: EC50 level in remifentanil inhibition of tracheal intubation response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain improvements at the midsection of the tendon
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain improvements at the musculotendinous junction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of OBI-positive vaccinated children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean viral load for OBI-positive cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Favorable fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNS disease control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CNS progression-free survival time
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in back extensor strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Management of non-union of long bone fractures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Edinburgh Postnatal Depression Scale (EPDS) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Hamilton Rating Scale for Depression (HRSD) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: major stroke rate
Endpoint domain: Mortality/survival
Primary endpoint: symptomatic improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Inhibition of bronchoconstrictor response to AMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Production of IFNG, TNF, and IL2 by CD8+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: FSFI total score improvement
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: 10-year BCFI
Endpoint domain: Mortality/survival
Primary endpoint: Tolerability of ipragliflozin
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of neurological function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Activities of daily living score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Proportion of dependent survival patients
Endpoint domain: Mortality/survival
Primary endpoint: Antibody response to DTaP vaccine antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Injection site reactions (redness, swelling, pain)
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in composite index of response variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in number of joints with pain on motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in pain-severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life benefit
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perceived difficulties in negotiating stairs
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in visual analogue scale scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Severe incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Leakage that interferes with daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dose of propofol required to produce loss of consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric fluid volume at induction of anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Gastric fluid pH at induction of anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean time taken for arch bar placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of glove perforations
Endpoint domain: Adverse events/effects
Primary endpoint: Loop formation upon endoscope insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discomfort and pain (VAS score)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: uNTX concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sBAP concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in urine mevalonate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in plasma mevalonate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma noradrenaline levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilation during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sensation of exertion
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: courageous coping
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: social integration
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: family environment
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: GLUT4 mRNA expression in adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequencies of menstrual bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of lipid-lowering therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postpartum depression prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity Level (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of CD4(+) CD25(+) Tregs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proliferative activity of T lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression of HLA-DR on CD14(+) monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: duration of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ovulatory cycles or pregnancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: standardized discharge scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visceral adipose tissue (VAT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Trunk fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean recalled pain on the visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive birth experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pediatric Crohn's disease activity index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in GH concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in IGF-1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in PRL secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Foetal sac discharge duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percent time with FoG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in calculus detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in somatic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insertion success rate on first attempt
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laryngeal seal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric tube insertion success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive feelings about patient recovery
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Social environment quality
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Postprandial increase in triglycerides (TG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in low-density lipoprotein cholesterol (LDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in high-density lipoprotein (HDL) constituents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: lower extremity injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Epinephrine levels during hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: skin and hair impairment indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: kindergarten achievement test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: teacher-rated academic performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Social participation increase
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: risk of all-type injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of alcohol-related injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of serious injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in somnolence severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum triglyceride concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean monthly headache days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: elevations of serum ALT levels
Endpoint domain: Adverse events/effects
Primary endpoint: Post-test scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Simulated case scenario task performance completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of enamel decalcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of enamel calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enamel Decalcification Index (EDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes